Deletion of the SUMO1 was suggested as a possible target for anti-HD drugs as deletion of the corresponding gene in the mouse model, as well as the use of a SUMOylation inhibitor in cell cultures, resulted in the autophagy stimulation and lower levels of mHTT [37]. The gene discussed is SUMO1; the disease is Huntington disease.